Rachel is the Director of Clinical Operations at Rinri Therapeutics, a biotech realising the potential of cell therapies to treat hearing loss. A hearing scientist by training, Rachel has worked in translational research and clinical trials within both public and private sector since 2007. She has extensive experience leading teams in the delivery of multi-centre, multi-national , drug, interventional and surgical trials.
